Document:

Exhibit 10.1

 

 

 

 

ASSET
PURCHASE AND SALE AGREEMENT

 

 

THIS ASSET
PURCHASE AND SALE AGREEMENT (hereinafter “Agreement”) is dated as of September 28, 2022, by and between Jai Chamunda New Hudson
LLC, a Michigan Limited Liability Company d/b/a New Hudson Pharmacy (“Seller"), with a notice address of 56270 Grand River
Ave, New Hudson MI, 48165, and Golden Developing Solutions Inc, a Nevada company/subsidiary TBD (“Buyer"), with a notice address
of P.O Box 460573, Fort Lauderdale, FL 33346.

 

WHEREAS,
The Seller is the operator of a pharmacy (“Store”) located as set forth on Exhibit 1 attached hereto and incorporated herein
by reference (“Premise”).

 

WHEREAS, The
Seller owns certain assets in connection with its operation of the Store, which Seller desires to sell to Buyer, and Buyer desires to
purchase from Seller, all subject to and upon the terms hereinafter set forth;

 

WHEREAS,
following Closing (as hereinafter defined), the acquired Assets (as hereinafter defined) located at the Premise will be transferred to
Orchard Trails Pharmacy, located in Farmington, MI being purchased by the Buyer on October 14th, 2022.;

 

WHEREAS,
Shreya Mehta owns all of the outstanding membership interests of Jai Chamunda New Hudson, LLC. (“Member”); and

 

NOW THEREFORE,
for and in consideration of the mutual covenants and agreements hereinafter set forth, and for other good and valuable consideration,
the receipt and sufficiency of which is hereby acknowledged, Buyer and Seller agree as follows:

 

	1.	ASSETS; PURCHASE PRICE.

 

(a)           
Assets. Subject to the terms and conditions of this Agreement, Seller agrees to sell, transfer, assign and convey to Buyer,
free and clear of all liens, security interests and other encumbrances, the following described assets (collectively, the “Assets”):

 

		(i)	Inventory.

 

(A)          
All prescription merchandise at the Store (collectively, the “Inventory”) set forth in the inventory instructions attached
hereto as Schedule A (the “Inventory Instructions”), subject to the exclusions set forth on Schedule A.

 

(B)          
The purchase price for the prescription merchandise shall be based on the Seller’s cost of said merchandise.

 

 

 

    	 	1	 

     

    

 

		(ii)	Prescription Files.

 

(A)          
All prescription files and records, maintained and/or generated by Seller in the course of operating its licensed pharmacy in the
Store (hereinafter, collectively, “Seller’s Rx Data”) from the Date of Inventory (as hereinafter defined) and going
back no less than the greater of (i) the period of time required by federal and state law or (ii) one (1) year (the “Required Time
Period”). Seller’s Rx Data shall include all hard copy prescriptions, signature logs, patient profiles, patient refill histories,
customer lists, and all electronic data of the same maintained in any format by Seller. If Seller has not operated in the Store for the
Required Time Period prior to the Date of Inventory, the Required Time Period shall be such shorter period as Seller has operated in the
Store. In addition, to the extent Seller’s Rx Data is maintained in electronic format, Seller and Buyer shall coordinate with Liberty
Software to transfer the files in the Seller’s server to the Buyer’s server located at Orchard Trails Pharmacy. Seller will
work in good faith with Buyer to effectuate the transfer of Seller’s Rx Data to Buyer with Liberty Software.

 

Seller’s Rx Data shall be
transferred to Buyer exclusively, shall not be shared with any third parties, and shall not be diminished or removed from the Store between
the date of execution of this Agreement and the Date of Inventory.

 

(B)          
The purchase price for Seller’s Rx Data shall be as set forth on Exhibit 1.

 

(iii)            
Goodwill. In consideration of Buyer’s acquisition of the Inventory and Seller’s Rx Data as set forth above,
and at no additional cost to Buyer, all goodwill with respect to the Assets being sold hereunder.

 

(b)           
Excluded Assets; No Assumption of Liabilities. This sale does not include, without limitation, furniture, trade fixtures,
equipment, vehicles, leases, (except as set forth in Section 2(d) below), cash and equivalents, or accounts receivable of Seller, all
rights to bill and collect from patients and third-party payors for services rendered before the Closing Date, all provider numbers, licenses,
Liberty pharmacy prescription data server, liquor license, liquor inventory or any asset related to liquor (as defined by Seller). Further,
Buyer shall not assume, or be obligated to perform, pay or otherwise discharge, any liability or obligation of Seller of any nature whatsoever,
including, without limitation, any type of successor liability, as a result of this transaction. Without limiting the foregoing, Seller
expressly acknowledges and agrees that Buyer is not assuming, and Buyer expressly disclaims and declines assumption any and all obligations
and/or liabilities of the Seller or the Assets arising from or related to acts or omissions occurring on or prior to the Date of Inventory.

 

(c)           
Purchase Price. The purchase price payable under Sections 1(a)(i)(B) and 1(a)(ii)(B) are hereinafter referred to as the
“Purchase Price” and, along with any additional amounts to be paid pursuant to Section 7(b), shall be the aggregate purchase
price to be paid by Buyer for all assets and rights transferred to Buyer hereunder. The Purchase Price, in its entirety, shall be paid
at Closing. However, within three (3) days after the last dated signature of this Agreement, Buyer shall deposit with StillwellRx, Seller’s
Broker, the sum of Twenty-Five Thousand Dollars ($25,000.00)

 

(“Refundable Deposit”),
which sum must be held in StillwellRx Escrow account and applied towards Purchase Price at Closing. The Refundable Deposit will be fully
refundable to Buyer in the event that Buyer is unsuccessful in closing the transaction of Orchard Trails Pharmacy, on or before, October
14, 2022, and the cause for failure to close the transaction of Orchard Trails Pharmacy is due Orchard Trails Pharmacy’s default
in any of the conditions precedent to close in the purchase agreement dated September 23, 2022 between Buyer and Orchard Trails Pharmacy.

 

(d)           
Seller Form W-9. On the date hereof, Seller shall complete, and return to Buyer, the attached Form W-9.

 

 

 

 

    	 	2	 

     

    

 

	2.	ADDITIONAL AGREEMENTS OF THE PARTIES.

 

(a)           
Access and Information. Subject to and in compliance with applicable law, prior to Closing, Seller will provide Buyer
and its authorized representatives with the following in connection with Buyer’s transition related planning activities: (i) such
operating data and other information relating to Seller’s business and Assets as Buyer may reasonably request. Buyer and Seller
acknowledge that each is a “Covered Entity” as that term is defined under HIPAA. To facilitate the transition of care from
Seller to Buyer, it may be necessary for Buyer to have access to electronic patient records prior to the Closing. Commencing on the date
hereof and in anticipation of the transaction contemplated hereby, Seller and Buyer will engage Liberty Software to transfer data from
the Seller’s server to the Buyer’s server on the evening before the Closing. Buyer agrees to implement appropriate safeguards
to restrict the access and use of the Seller’s Rx Data prior to Closing for data migration and integration purposes. If for whatever
reason the transaction does not close, Buyer agrees to take reasonable steps to remove the Seller’s Rx Data from its active servers
and dispensing system.

 

(b)          
Pharmacy Information Systems. If the electronic transfer of Seller’s Rx Data is not completed by the Date of
Inventory, Seller agrees that Buyer will be provided a complete copy of the Seller’s complete prescription data via .csv file prepared
by Seller’s pharmacy operating system software vendor, at no additional cost to Buyer. At no point shall Buyer have any access or
control over Seller’s data server. Seller represents, warrants and covenants that the Information Systems shall be in working order
on the Date of Inventory and that Seller will maintain the Information Systems and any hardware and software support through the Date
of Inventory.

 

(c)          
Telephone. At no additional cost to Buyer, Seller agrees to cooperate with Buyer and assist with the transfer of
the main telephone and fax line and number(s) used in the operation of the Store to Buyer on the Date of Inventory. Buyer shall facilitate
the transfer or call forwarding, as applicable. Seller shall be solely responsible for the cancellation of, and final payment for, any
lines or services not transferred to Buyer hereunder. This includes, but is not limited to, main telephone and fax line, modem lines,
equipment leases, service contracts and advertising.

 

(d)           
Advertising; Social Media; Use of Name. At no additional cost to Buyer, Seller agrees that Buyer shall have the exclusive
right to use Seller’s trade names and “doing business as” names, but not to be registered with the state of Michigan,
in each case, for a period of six (6) months from the Date of Inventory, including, without limitation, to advertise Buyer's pharmacy
and the transfer of the prescription files to Buyer from Seller as described herein. At Buyer’s request, Seller shall arrange to
have Seller’s websites and/or social media accounts post a message notifying the public of the transfer of the prescription files
to Buyer from Seller as described herein. Following the Date of Inventory, Seller shall delete the Stores from its website and its social
media accounts. Except as provided above in this subsection (d), following the Closing, Seller and Member agree that each shall not use
Seller’s websites and social media accounts in connection with any pharmacy business related to the Stores and shall not, in the
United States or any foreign country, directly or indirectly, utilize the trade names or “doing business as” names of the
Store or any derivative thereof, in perpetuity.

 

(e)           
Notifications. Seller shall send all required notifications of the sale of the Assets hereunder and closing of the Store
to all applicable governmental authorities. Seller shall also surrender the pharmacy license for the Store to the applicable governmental
authority immediately after the Date of Inventory and supply evidence thereof to Buyer.

 

(f)           
Third Party Payors and Providers. Buyer expressly disclaims and declines assumption of any of Seller’s third-party
provider numbers or licenses. Buyer shall not assume, and shall not be deemed to have assumed, any and all obligations and/or liabilities
of the Seller, the Store or the Assets with respect to all third-party provider numbers and licenses and said obligations and/or liabilities
shall remain with Seller. Seller acknowledges that Buyer maintains relationships with several third-party payors and providers and that
such relationships may change from time to time without notice. Seller further acknowledges that it did not rely on the continuation of
Buyer’s current relationship with any third-party payor or provider when entering into this Agreement. The terms and provisions
of this Section 2(f) shall survive the Closing.

 

(g)          
Contingencies.  This Agreement and closing is contingent upon Buyer having a licensed pharmacy, PIC, and location operating
at the time of closing to engage in business with.

 

 

 

 

    	 	3	 

     

    

 

	3.	CONDUCT OF BUSINESS.

 

From the date of this Agreement
until the Closing, except as otherwise provided in this Agreement or approved in writing by Buyer, Seller will comply with the following
covenants:

 

(a)           
No Material Changes. Seller will carry on and maintain its business at the Store and maintain the Assets in the ordinary
course of business and in substantially the same manner as heretofore conducted. Seller shall use commercially reasonable efforts to maintain
the prescription volume at the Store and will not remove or transfer any Assets from the Store other than in the ordinary course of business.

 

(b)           
Compliance with Laws. Seller will duly comply with all laws applicable to its business, the Store and the Assets.

 

(c)           
No Encumbrances. Seller will not suffer or permit the creation of any lien or encumbrance upon any of the Assets, except
as otherwise disclosed on Schedule 3(c).

 

(d)          
Maintenance of Insurance. Seller will maintain all of the insurance policies in effect as of the date hereof unless replaced
by policies which are substantially comparable to such policies.

 

(e)           
Notification. Seller shall advise Buyer in writing promptly, but in any event prior to the Closing, of: (i) the occurrence
of any event which renders any of the representations or warranties set forth herein inaccurate or the awareness of Seller that any representation
or warranty set forth herein was not accurate when made; (ii) any fact that, if existing or known on the date of this Agreement would
have been required to be set forth or disclosed pursuant to this Agreement; and (iii) the failure of Seller to comply with or accomplish
any of the covenants or agreements set forth herein. Any notice given pursuant to this Section 3(e) shall not operate to cure any breach
of the representations and warranties made by Seller herein or in any Exhibits or Schedules hereto.

 

	4.	PHYSICAL INVENTORY; CLOSING.

 

(a)           
Store Closings. On the evening prior to the Date of Inventory, Seller shall close the Pharmacy to the general public and
the Pharmacy shall remain closed thereafter. Nevertheless, Seller shall have the right to continue the operation of selling non-prescription
merchandise.

 

(b)           
Date of Inventory. A physical inventory count and valuation at the Store shall be taken on the dates set forth on Exhibit
1 (the date on which such physical inventory is actually taken is referred to herein as the “Date of Inventory”). Prior to
the commencement of the physical inventory, Seller shall reverse and return all filled and undelivered prescriptions at the Store to stock
in accordance with applicable governmental regulations, laws and requirements, providing all necessary notice to any third-party payors,
reversing any adjudicated claims made in respect of such prescriptions, and shall provide Buyer with a list of such prescriptions so that
Buyer is prepared to fill such prescriptions after the inventory. RGIS Inventory Service and/or any other independent firm selected by
Buyer (the “Inventory Service”) shall conduct the physical inventory, at Buyer’s expense, using the categories and cost
factors listed in the Inventory Instructions, attached hereto and made a part hereof. Seller and Buyer shall each arrange to have its
personnel present on the Date of Inventory, who shall monitor and assist in same.

 

 (c)            Closing. The closing of the purchase and sale of the Assets (hereinafter the “Closing”) shall take place on Closing Date after the completion of the physical inventory of the Store on the Date of Inventory, subject to the satisfaction or waiver of the conditions precedent to Buyer’s obligation to close set forth in this Agreement, including, without limitation, in Section 6. Possession and control of the Assets, and the risk of loss or damage to the Assets, shall be transferred to Buyer upon the Closing. On the Closing, Buyer shall pay to Seller an amount equal to the Purchase Price, by wire transfer, or certified check, to an account supplied by Seller. Notwithstanding the foregoing, Buyer shall not be required to make any payment hereunder until all conditions precedent to Buyer’s obligations hereunder have been satisfied or waived in writing by Buyer. By execution of this Agreement, Seller agrees to the manner and form of payment described in this paragraph and that Buyer, upon making said payment in said manner and form, shall conclusively be deemed to have fulfilled its payment obligations hereunder.

 

 

 

    	 	4	 

     

    

 

 (d)           Closing Date. The closing of the transactions provided for in this Agreement (the “Closing Date”) shall occur on or before October 31, 2022, at a date, time and location to be agreed upon by Seller and Purchaser

 

(e)           
Creditor List and Payoff Letters. Seller represents and warrants that a complete and accurate list of all secured creditors
which have or may have any interest in the Assets is attached hereto as Schedule 3(c), and that such list contains all of the names,
addresses, as well as the amount owed, and the name of any persons who may assert claims even though the claim may be disputed. On or
before the Date of Inventory, as a condition precedent to Buyer’s obligation to close hereunder, Buyer shall have received from
Seller an updated creditor list and evidence of the release of all liens, security interests and other encumbrances encumbering any of
the Assets, in form and substance satisfactory to Buyer in its sole discretion, including, without limitation, any UCC-3 Termination Statements,
pay-off letters or similar documents required by Buyer. Notwithstanding anything herein to the contrary, payment of the Purchase Price
shall be paid to the Seller or, at Buyer’s option, paid directly to Seller’s secured creditors. Seller represents, warrants
and covenants that, as of the Closing, Seller's creditors will be paid in full and all of the Assets shall be free and clear of any and
all security interests, liens and other encumbrances, including, without limitation, those set forth on Schedule 3(c). Should Seller,
for whatever reason, fail to pay its creditors and should said creditors then proceed in any manner against Buyer and/or the Assets, and
should Buyer suffer any loss as a result of the actions of Seller's creditors, then Buyer shall have, without limiting any other remedies
available to it hereunder, at law or in equity, the right to deduct any such losses directly from the payments to be made to Seller or
Member according to the terms of this Agreement or any agreement entered into in connection herewith, including, without limitation, sums
payable under Section 7(b) hereof.

 

(f)            
Forwarding of Funds. Buyer agrees to forward to Seller any sums of money received by Buyer for pharmacy services rendered
by Seller prior to the Date of Inventory. Seller agrees to forward to Buyer any sums of money received by Seller for pharmacy services
rendered by Buyer following the Date of Inventory.

 

	5.	REPRESENTATIONS AND WARRANTIES OF SELLER.

 

As of the execution of this Agreement
and the Closing, Seller hereby represents and warrants to Buyer as follows:

 

(a)           
Organization and Authorization. Seller’s entities are a corporation and a limited liability company duly organized,
validly existing and in good standing under the laws of the State of Michigan and in good standing in all states in which Seller conducts
its business. Seller and Member have the requisite power and authority to execute and deliver this Agreement and perform their respective
obligations hereunder. This Agreement has been duly and validly authorized, executed, and delivered by Seller and Member and constitutes
the legal, valid, and binding obligations of Seller and Member, enforceable in accordance with its terms, subject to applicable bankruptcy,
insolvency, reorganization, and other similar laws affecting the enforceability of creditors’ rights generally, general equitable
principles, and the discretion of courts in granting equitable remedies.

 

(b)          
Title. Seller is the sole owner of and has good and merchantable title to all of the Assets, and all the Assets are free
and clear of security interests, liens and other encumbrances, except (as of the execution of this Agreement only) as set forth on Schedule
3(c).

 

(c)           
Licenses and Permits. Seller possesses all permits, authorizations, certifications of governmental and non-governmental
authorities, and licenses necessary for the operation of its business in the Store and the same are in full force and effect and neither
Seller nor Member has received notice of, nor is there any pending or any threatened proceeding relating to, the revision, cancellation
or termination of any such permits, authorizations, certifications, or licenses.

 

 

 

    	 	5	 

     

    

 

(d)          
No Legal Actions. To the best of Seller’s knowledge, there are no (i) claims, actions, suits, labor disputes, arbitration,
legal or administrative proceedings or investigations, including, without limitation, by the DEA, OIG, CMS, FDA, applicable Board of Pharmacy
or other governmental body, pending against Seller or Member or threatened against Seller or Member, or otherwise pending or threatened
with respect to the Seller's operations, the Assets, any parent, subsidiary or other affiliate of Seller, or any director, member, manager,
officer or employee of the Seller or any such affiliate, and no such actions, disputes, proceedings or investigations are contemplated
or (ii) judgments, decrees, orders, writs, injunctions, rulings, decisions or awards of any court or governmental body to which Seller
or Member is a party or is subject or to which any of the Assets is subject, or is otherwise pending or threatened against Seller or Member.
Neither Seller nor Member has received any notice of complaints filed against Seller under HIPAA or applicable patient privacy and data
protection laws and, to Seller’s knowledge, there has been no violation of such laws.

 

(e)           
Compliance with Laws. To the best of Seller’s knowledge, Seller’s conduct with its business has not violated
in any respect, and is in compliance in all respects with, any and all local, state, federal, and foreign laws, statutes, ordinances,
regulations, rules, codes, judgments, decisions, decrees, and orders (“Laws”). Neither Seller nor Member has received any
notice or complaint to the effect that, or otherwise been advised that, it is not in compliance with or it is in violation of any such
Law. Seller has timely filed all material reports, registrations and statements required to be filed by it with any governmental body
and has paid all related fees and assessments due and payable, in each case with respect to the Store. None of Seller, Member, any parent,
subsidiary or other affiliate of Seller, nor any director, member, manager, office or employee of Seller or any such affiliate has been
notified, or is aware of, of any inquiry, investigation or similar proceeding from any governmental body, been sanctioned, or had a sanction
proposed, by any governmental body, or received or filed for any Medicare or Medicaid overpayments or other improper billings with respect
to the Store. All Medicare, Medicaid and third-party reports and claims filed or required to be filed with respect to the Store have
been timely filed and are complete and accurate in all material respects. Such reports and claims properly claim and disclose all information
and other items to be disclosed for the periods covered thereby. None of Seller, Member, any parent, subsidiary or other affiliate of
Seller, nor any director, member, manager, office or employee of Seller or any such affiliate has been disciplined or sanctioned, or
has had a discipline or sanction proposed, by any governmental body or excluded from participation in any government healthcare payment
program, including Medicare or Medicaid, nor are any of the foregoing persons aware of any pending or threatened discipline, sanction,
inquiry, investigation or government action that may lead to such exclusion, fine or other remedy. Seller is in compliance with and has
submitted all reports and other information required by, all prescription monitoring programs or other similar programs maintained by
governmental or regulatory authorities and is not aware of and has not received any notice of, or otherwise been advised of, any errors
in any such submissions.

 

(f)            
Employees; Labor Matters. To the best of Seller’s knowledge, Seller has complied and is in compliance with, in all
respects, applicable legal requirements pertaining to the employment of labor, including but not limited to those relating to wages, benefits,
hours, FMLA, ADA accommodations, collective bargaining, discrimination, drug testing, polygraphs, harassment, retaliation or wrongful
discharge, or requiring leave or other accommodation or otherwise regarding terms and conditions of termination from employment, worker’s
compensation, immigration, plant closings and unemployment compensation, and there are no claims, causes of action, charges, suits, complaints,
administrative proceedings, arbitrations, material labor grievances, or government investigations or proceedings, pending or, to the knowledge
of Seller or Member, threatened against Seller in connection therewith. Seller has not received notice of, nor does Seller or Member have
knowledge of any matter that could reasonably form the basis for, any such claims. There are no collective bargaining agreements covering
any employees of Seller, no collective bargaining agent has been certified as a representative of any of the employees of Seller, and
no representation campaign or election is now in progress with respect to any of the employees of Seller.

 

(g)           
No Violation or Conflict. Neither the execution and delivery of this Agreement, nor the performance of its obligations hereunder,
by Seller or Member is a violation of any provision of its articles of incorporation, organization or bylaws, or any law, rule, regulation,
order, writ, injunction, judgment, decree, contract, or other obligation to which it is a party or to which it, the Store or the Assets
are subject.

 

(h)          
Consents. No consent or approval by, or filing with, any governmental authority or any other person or entity is required
in connection with the execution and delivery by Seller of this Agreement or the consummation by Seller of the transactions contemplated
hereby.

 

 

 

    	 	6	 

     

    

 

(i)            
Taxes. All federal, state, county, and local tax and other returns and reports required and due to be filed with respect
to Seller, the Assets, or both have been filed, and all taxes, levies, license and registration fees, charges or withholdings of any nature
whatsoever, including, without limitation, excise, sales, use, transfer, property gains, and ad valorem taxes (collectively, “Taxes”)
have been paid, or adequate provision for the payment thereof has been made. Buyer will not be responsible for, and Buyer specifically
assumes no obligations to pay, any Taxes or withholding any Taxes or any other similar liability or obligation of Seller. Seller is not
in default of the payment of any Taxes due or payable or of any assessments received in respect thereof and Seller has not waived any
statute of limitations in connection with or granted any extension of a period for the assessment of, any Tax. Seller is not a “foreign
person” as that term is used in Treasury Regulations Section 1.1445.2.

 

(j)            
Disclosure. Neither this Agreement nor any of the schedules or exhibits hereto contains or will contain when delivered at
Closing any untrue statement by Seller of a material fact or will omit to state a material fact necessary to make the statements contained
herein or therein, in light of the circumstances in which they were made, not misleading.

 

(k)           
Prescriptions; Seller’s Rx Data. The prescriptions filled at the Store have arisen from bona fide, legal transactions.
Seller’s Rx Data has been accessed, collected, compiled, disclosed, maintained, and stored in compliance with any and all local,
state, federal, and foreign laws, statutes, ordinances, regulations, rules, codes, decisions, decrees, and orders, and are consistent
with industry standards and clinical guidelines applicable to pharmacists and licensed prescribers. Seller’s Rx Data is complete
and accurate.

 

(l)            
Controlled Substances Inventory. To the extent required by applicable law or DEA regulations in the context of the transaction
contemplated by this Agreement, Seller has undertaken and delivered to Buyer a complete and accurate inventory of all controlled substances.

 

(m           
DEA Recordkeeping. To the best of Seller’s knowledge and understanding, Seller has provided to Buyer all records
in its possession that are required to be maintained by DEA regulations for the prior two-year period.

 

(n)           
Insurance. Seller is insured with responsible insurers (including, without limitation, general liability insurance coverage
and Causes of Loss-Special Form insurance covering the Assets) against risks normally insured against by similar businesses under similar
circumstances.

 

(o)          
Prohibited Persons and Transactions. Each of Seller and each Member (i) is not a person or entity with whom U.S. persons
or entities are restricted from doing business under regulations of the Office of Foreign Assets Control (“OFAC”) of the Department
of the Treasury (including those named on OFAC’s Specially Designated Nationals and Blocked Persons List) or under any statute,
executive order (including the September 24, 2001, Executive Order Blocking Property and Prohibiting Transactions with Persons Who Commit,
Threaten to Commit, or Support Terrorism), or other governmental action, and (ii) has not been convicted, pleaded nolo contendere, indicted,
arraigned or custodially detained on charges involving money laundering or predicate crimes to money laundering.

 

(p)           
Ownership. The Member owns all of the outstanding membership interests eller free and clear of any lien or other encumbrance.
There are no options, warrants, calls, rights, agreements, arrangements or undertakings of any kind (contingent or otherwise) obligating
Seller to issue, deliver or sell, or cause to be issued, delivered or sold, any shares of stock, membership interests, partnership interests
or any other securities of Seller.

 

The foregoing
representations and warranties shall survive the Closing and remain in full force and effect thereafter.

 

 

 

 

    	 	7	 

     

    

 

	6.	CONDITIONS PRECEDENT.

 

It is agreed
that the obligations of Buyer under this Agreement are strictly contingent upon and subject to the satisfaction of each of the following
conditions precedent on or before the Date of Inventory:

 

(a)           
Closing Certifications. Seller will have performed and complied in all material respects with all agreements, covenants
and obligations contained in this Agreement that are required to be performed or complied with by it at or prior to the Closing and each
of the representations and warranties of Seller contained in this Agreement shall be true and correct in all material respects on the
Date of Inventory as though made on the Date of Inventory.

 

(b)           
No Material Adverse Change. Since the date of this Agreement, there will not have been any material adverse change in the
Assets or the business, operations, results of operations or condition (financial or other) of the Store, and no event has occurred or
circumstance exists that may result in such a material adverse change.

 

(c)           
Closing Documents. Buyer will have received a fully executed Bill of Sale and Closing Statement in a form attached hereto
as Exhibit A and the updated creditor list (if any), and all applicable terminations, pay-off letters and other documents required
pursuant to the terms of Section 4(e) hereof.

 

(d)           
No Governmental Order. No provision of any applicable Law or governmental order, judgment, decree or ruling shall prohibit
the consummation of the transactions contemplated hereby.

 

(e)           
Transfer of Seller’s Rx Data. The conversion and transfer of Seller’s Rx Data to Buyer, as contemplated in Section
1 hereof, shall be complete.

 

(f)           
Prescription Monitoring Compliance. Prior to Closing, at Buyer’s request, Seller shall have provided Buyer with evidence
of Seller’s compliance with applicable prescription monitoring programs or similar programs, including, without limitation, evidence
that there are no outstanding errors in Seller’s submissions pursuant to such programs, in form and substance satisfactory to Buyer
in its reasonable discretion.

 

	7.	CONSULTING; NON-COMPETITION COVENANTS.

 

(a)           
Covenant. Shreya Mehta, personally, covenants and agrees to not directly or indirectly, during the period commencing on
the Date of Inventory and expiring on the second (2nd ) anniversary of the Date of Inventory (the “Restrictive Period”):
(i) within a radius of ten (10) miles of the Store location of 56270 Grand River Ave., New Hudson, MI 48165 (the “Territory”),
either directly or indirectly, be employed by, form, acquire, invest in, finance, own, operate, manage, assist, support, provide directly
or indirectly with, whether as a Member, partner, lessor, lessee, member, joint venture, advisor, employee, consultant or independent
contractor, an enterprise (a “Competing Business”) which is engaged in the business of any retail pharmacy; (ii) hire, engage,
employ or interfere with, or attempt to hire, engage, employ or interfere with, either directly or indirectly, any employees, representatives
or agents of Buyer, or any affiliates controlling, controlled by, or under common control with Buyer (an “Affiliate”), in
the Territory, or induce or attempt to induce, either directly or indirectly, any of them to leave the employ of Buyer or any Affiliate,
or violate the terms of his or her contract with Buyer or any Affiliate; or (iii) call upon, solicit, advise or otherwise do or attempt
to do, business with any clients, suppliers, customers or accounts of the business of Seller or the Buyer or any Affiliate in the Territory
or take away or interfere or attempt to take away or interfere with any customer, trade, business or patronage of the business of Seller
or the Buyer or any Affiliate in the Territory. Notwithstanding anything herein to the contrary, Seller shall not deliver prescriptions
into or within the Territory. This non-competition covenant does not prohibit Seller from operating a business selling non-prescription
merchandise.

 

 

 

    	 	8	 

     

    

 

(b)           
Consideration. In consideration of the foregoing covenant, in addition to the purchase of the Assets hereunder, Buyer agrees
to pay to the Member the total sum as set forth on Exhibit 1. The Member acknowledges that they will receive substantial benefit from
the purchase of the Assets hereunder. With respect to Seller, the purchase of the Assets hereunder shall be deemed to be good and sufficient
consideration for said covenant not to compete. Payment shall be made to the Member or, at Buyer’s option, paid directly to Seller’s
secured creditors. Payment to Member, if any, shall be made by wire transfer to an account designated by Member or by corporate check
payable to Member. Payment shall be delivered on Closing Date. Seller and Member acknowledge and agree that (i) the foregoing covenants
are a material inducement to Buyer to enter into this Agreement, and Buyer is doing so in reliance upon each of the Seller and Member
agreeing to be bound by such covenants; and (ii) in light of such reliance, the amount allocated herein is not intended by the parties
as a measure of damages that might be incurred by Buyer in the event of a breach of any such covenant.

 

(c)           
Remedies. The Seller and Member hereby agree that if either or both shall breach the provisions of this Section 7, it will
cause irreparable damage to Buyer and in the event of such breach Buyer shall have available all its right and remedies at law or in equity,
including, without limitation, the right to a reimbursement from the Member of the consideration paid hereunder and the right to injunctive
relief. The terms and provisions of this Section 7 shall survive the Closing.

 

(d)          
Consulting. After Closing, Seller, for a period of thirty (30) days commencing form Closing Date shall be available to consult,
as an independent contractor, for Purchaser, no more than five (5) days a week (Monday to Friday), for a maximum of forty (40) hours per
week, if necessary. Purchaser agrees to compensate Seller at the rate of $125.00 per hour, which payment shall be made on a bi-weekly
basis upon Seller submitting an invoice to Purchaser.

 

	8.	ACCESS TO INFORMATION.

 

(a)           
PHI. After the Date of Inventory, Buyer shall use commercially reasonable efforts to make the Protected Health Information
(as defined hereinafter) that is part of Seller’s Rx Data available for access to patients and disclosure to other authorized third
(3rd) parties in accordance with the Health Insurance Portability and Accountability Act of 1996, as amended by Subtitle D
of the Health Information Technology for Economic and Clinical Health Act, Title XIII of Division A and Title IV of Division B of the
American Recovery and Reinvestment Act of 2009 (Pub. L. No. 111-5) (the “HITECH Act”) and the federal regulations (“HIPAA
Rules”) published at 45 CFR parts 160 and 164 and any applicable state privacy and security laws regarding individually identifiable
health information and other applicable laws. For the purposes of this Agreement, Protected Health Information shall have the same meaning
as such term is defined in 45 CFR 160.103. Seller acknowledges and agrees that notwithstanding the foregoing, Buyer shall not assume
any legal obligations or liabilities of Seller under the HIPAA Rules relating to any uses and disclosures of Protected Health Information
made prior to the Date of Inventory. All inquiries, including those relating to patient rights or the Seller’s obligations under
the HIPAA Rules relating to any uses and disclosures of Protected Health Information made prior to the Date of Inventory shall be forwarded
to Seller or its designated agent for handling.

 

(b)           
RX Data. Seller shall retain copies of Seller’s Rx Data transferred to Buyer pursuant to this Agreement to the extent
required by, and in accordance with, applicable law. Following Closing, Seller and Buyer each shall preserve in accordance with the applicable
record keeping requirements and regulations of Medicare, Medicaid, the FDA, the DEA and state pharmacy boards in jurisdictions that Seller
and Buyer conduct business all records possessed by such party relating to the business at the Store prior to the Closing Date. To the
extent permitted in accordance with the HIPAA Rules and other applicable laws, Buyer hereby agrees to make available to Seller, in a form
reasonably determined by the Buyer, copies of Seller’s Rx Data transferred to Buyer pursuant to this Agreement if, after the Closing
and for a legitimate business reason, Seller requires copies of such Seller’s Rx Data.

 

To the extent
Seller retains or is given access to Seller’s Rx Data, Seller agrees to hold all such documentation and information in confidence
and to take commercially reasonable measures to prevent any unauthorized disclosures thereof. Seller further agrees that it will not use
Seller’s Rx Data for any purpose after Closing except as required by law, in connection with pending litigation, or the resolution
of third-party claims. Without limiting the foregoing, neither Seller nor any of its affiliates will solicit, whether by mail, internet
or any other means, any of the patients whose records are being transferred to Buyer pursuant to this Agreement. In the event that Seller
is requested or required by law, subpoena, court order, or other similar legal process to disclose all or any portion of Seller’s
Rx Data transferred to Buyer pursuant to this Agreement, Seller may make such disclosure, provided it will provide Buyer with prompt written
notice thereof.

 

The terms and provisions of this Section 8 shall survive the
Closing.

 

 

 

    	 	9	 

     

    

 

	9.	BUYER’S INDEMNIFICATION OBLIGATION.

 

Buyer shall
indemnify and defend Seller, and hold Seller harmless, from and against any and all losses, costs, expenses, claims, damages, liabilities,
actions, proceedings, investigations, injunctions, judgments, orders, rulings, fines (and interest and penalties, if any) (collectively,
“Losses”), including, without limitation, court costs and reasonable attorney’s fees, arising out of or resulting from
(a) any breach of any representation or warranty of Buyer contained in or given in writing pursuant to this Agreement, or in any other
agreement or instrument delivered in connection herewith, (b) any breach or nonfulfillment by Buyer of any covenant or obligation contained
in this Agreement or in any other agreement or instrument delivered in connection herewith, or (c) Buyer’s possession or use of
the Assets after the Date of Inventory. The terms and provisions of this Section 9 shall survive the Closing.

 

	10.	SELLER’S INDEMNIFICATION OBLIGATION.

 

Seller shall
indemnify and defend Buyer, its subsidiaries and affiliates, and each of their respective directors, members, managers, officers, employees
and agents (each, a “Buyer Indemnified Party”), and hold each Buyer Indemnified Party harmless, from and against any and all
Losses, including, without limitation, court costs and reasonable attorney’s fees, arising out of or resulting from (a) any breach
of any representation or warranty of Seller contained in or given in writing pursuant to this Agreement, or in any other agreement or
instrument delivered in connection herewith, (b) any breach or nonfulfillment by Seller of any covenant or obligation contained in this
Agreement or in any other agreement or instrument delivered in connection herewith, (c) any and all liabilities and obligations of every
nature and description of Seller, or (d) Seller’s possession or use of the Assets, the Premises or the Store up to and including
the Date of Inventory, Seller’s operations prior to or on the Date of Inventory, Seller’s third party provider numbers or
licenses, Seller’s Existing Leases, or any other events, acts or omissions of Seller which occurred prior to or on the Date of Inventory,
including, without limitation, claims or actions brought against Buyer under Seller’s Existing Leases based on events, acts or omissions
of Seller which occurred prior to or on the Date of Inventory. The terms and provisions of this Section 10 shall survive the Closing.

 

	11.	EMPLOYMENT.

 

Buyer, Seller,
and Member agree that Buyer has not offered any terms of employment to Member or to any of Seller’s employees as consideration for
the sale contemplated herein. It is agreed that in the event that Member and/or any employees of Seller shall be employed by Buyer as
the result of the Closing of the transaction contemplated herein, then each such Member and/or individual employee of Seller shall be
an “employee-at-will” of Buyer.

 

Buyer is
not assuming any liability or obligations related to any of Seller’s current or former employees. Without limiting the foregoing,
Seller acknowledges that no Benefit Plan, or obligation or liability related to any Benefit Plan, will be transferred to Buyer, and all
such Benefit Plans and related obligations and liabilities will remain with Seller, whether prior to, on or after the applicable Closing.
Seller shall be responsible for any liability under the WARN Act and any similar state or local law or regulation relating to plant closings
and layoffs with respect to Seller’s employees who are terminated on or prior to the Date of Inventory. The terms and provisions
of this Section 12 shall survive the Closing.

 

 

 

    	 	10	 

     

    

 

	12.	CONFIDENTIALITY.

 

(a)          
Confidentiality. Buyer and Seller hereby covenant and agree to keep the existence of this Agreement, the terms and conditions
of this Agreement, and any discussions, negotiations or other non-public information relating to this Agreement confidential and to not
disclose the same to any person or entity, including without limitation, employees and customers of Seller, except to the extent (i) approved
by the other party in writing, which approval shall not be unreasonably withheld, conditioned or delayed, (ii) expressly permitted hereunder
or otherwise necessary to carry out the party’s respective obligations hereunder, or (iii) required by law, subpoena or court order.

 

(b)          
Permitted Announcements. Notwithstanding the foregoing, following the full execution of this Agreement, Seller shall disclose
the existence of the transactions contemplated hereby to Seller’s employees, provided, however, that such disclosure shall only
be made after consultation and coordination with Buyer with regard to the content and timing of such disclosure. If Buyer so elects,
Buyer may have its representatives present at the time of any such disclosure to Seller’s employees. Following such disclosure,
if and as directed by Buyer, Seller shall provide notification of the transactions contemplated hereby to Seller’s customers, including,
without limitation, by posting signs in the Premises, bag tags and/or mailers. All such notifications shall be in a form provided by
Buyer or otherwise subject to Buyer’s prior approval. Without limiting the foregoing, no press release, news release, media release,
press statement or comment, social media communication, or other similar public announcement or communication related to this Agreement
or the transactions contemplated hereby will be issued by Seller, any Member or any of their respective affiliates without the prior
written approval of Buyer.

 

	15.	SURVIVAL.

 

The representations,
warranties and indemnities contained in this Agreement, and any covenants and agreements contained herein that by their terms expressly
survive the Closing or contemplate performance after the Closing, shall survive the Closing and continue in full force following the Closing.

 

	16.	MISCELLANEOUS.

 

(a)           
Applicable State Law. This Agreement shall be governed by and construed and enforced in accordance with the laws of the
state in which the Store is located.

 

(b)           
Severability. If any term or provision of this Agreement or the application thereof to any persons or circumstances shall
to any extent be invalid or unenforceable, the remainder of this Agreement or the application of such term or provision to persons or
circumstances other than those to which it is held invalid or unenforceable shall not be affected thereby, and each term and provision
of this Agreement shall be valid and enforceable to the fullest extent permitted by law.

 

(c)           
Notices. Any notice, request or other document to be given hereunder to any party shall (i) be in writing, (ii) delivered
personally, sent by certified mail, postage prepaid, or sent by a commercially recognized overnight courier, provided a receipt is required,
and (iii) if to Buyer, addressed to it at the address provided on Page 1 hereof, and if to Seller, addressed to it at the address provided
on Page 1 hereof, or at such other address as any party hereto shall indicate by writing as herein provided.

 

(d)          
Assignment; Successors and Assigns. Buyer shall have the absolute right to assign this Agreement or any of its rights or
obligations hereunder, and/or designate another party to take title to all or any of the Assets, without the consent of Seller, including
but not limited to, an assignment of the rights of Buyer under Section 7. If requested by Buyer, Seller shall cooperate by giving Buyer
written acknowledgement of any notice of such assignment and or designation received from Buyer in connection therewith. Seller may not
assign this Agreement, or any rights or obligations hereunder, without the written consent of Buyer. This Agreement shall bind and inure
to the benefit of the parties hereto and, subject to foregoing, their respective heirs, representatives, successors and assigns. This
terms and provisions of this Section 16(d) shall survive the Closing.

 

 

 

    	 	11	 

     

    

 

(e)           
Waiver of Trial by Jury. The parties hereto waive to the fullest extent permitted by law, trial by jury in any action,
proceeding or counterclaim brought by either of such parties against the other with respect to any matter whatsoever arising out of or
in any way connected with this Agreement.

 

(f)            
Headings; Construction. The headings of the Sections herein are inserted for convenience of reference only and will be ignored
in the construction or interpretation hereof. Unless the context clearly requires otherwise, (i) whenever the words “including”,
“include” or “includes” are used in this Agreement, they shall be interpreted in a nonexclusive manner, and (ii)
“or” is not exclusive.

 

(g)           
Further Assurances. Following the Closing, the parties will execute and deliver such documents and take such other actions
as may be reasonably requested from time to time by Buyer or Seller in order to fully consummate the transactions contemplated hereby.

 

(h)           
Third Party Beneficiaries. Nothing in the Agreement will be construed to confer any right, benefit or remedy upon any person
or entity that is not a party hereto or a permitted assignee of a party hereto, except as otherwise expressly set forth in this Agreement.

 

(i)            
Schedules and Exhibits. All schedules and exhibits to this Agreement are an integral part of this Agreement and are incorporated
herein by reference for all purposes of this Agreement.

 

(j)            
Entire Agreement. This Agreement and the agreements, exhibits, schedules and certificates referred to herein or delivered
pursuant hereto constitute the entire agreement between the parties hereto with respect to the purchase and sale of the Assets and supersedes
all prior agreements and understandings.

 

(k)           
Amendment; Waiver. This Agreement may be amended, supplemented or otherwise modified only by an agreement in writing signed
by both parties hereto. The waiver by a party of any breach of any provision of this Agreement will not constitute or operate as a waiver
of any other breach of such provision or of any other provision hereof, nor will any failure to enforce any provision hereof operate as
a waiver of such provision or of any other provision hereof.

 

(l)             
Attorneys’ Fees. In the event a party shall be required to commence or defend any action or proceeding against any
other party by reason of any breach or claimed breach of any provision of this Agreement, to commence or defend any action or proceeding
in any way connected with this Agreement or to seek a judicial declaration of rights under this Agreement, the party prevailing in such
action or proceeding shall be entitled to recover from or to be reimbursed by the other party for the prevailing party’s reasonable
and actual attorneys’ fees and costs through all levels of proceedings.

 

(m)          
Counterparts; Electronic Signatures. This Agreement may be executed in separate counterparts each of which shall be an original
and all of which shall be deemed to be one and the same instrument. Buyer and Seller agree that a facsimile or .pdf signature on this
Agreement is as valid as an original signature.

 

(n)           
Arms-Length Transaction. Each of Buyer and Seller hereby acknowledge and agree that (i) it is not the purpose of this Agreement
or any of the transactions contemplated hereby to exert influence in any way over the judgment of any party with respect to the referral
of patients or business, (ii) it is the intent of the parties that any referrals that may be made by Seller to Buyer’s business
shall be based solely upon the professional judgment and discretion of the referring party while acting in the best interests of the patient,
and (iii) the consideration hereunder is consistent with fair market value in an arm's length transaction and no part of the purchase
price or other amounts payable hereunder takes into consideration the volume or value, if any, of referrals or business generated between
the parties.

 

 

 

    	 	12	 

     

    

 

	17.	PERSONAL PROPERTY TAXES.

 

Any ad valorem
taxes assessed against the personal property (as personal property is defined by the taxing jurisdiction(s) having taxing authority over
the Assets) transferred to Buyer in connections with the transactions contemplated hereby shall be apportioned between Seller and Buyer
as of midnight of the day preceding Date of Inventory. Such apportionment shall be made to the best of the parties' abilities at the time
of Closing based on the most recent personal property tax bill issued by the taxing jurisdiction(s). If final amounts are not known at
the time of Closing, such prorations shall be recalculated by Buyer and Seller when the final amounts become known, and Buyer and Seller
shall make any additional payment or refunds, as the case may be, so that the correct prorated amount is paid by each of Buyer and Seller.
The terms and provisions of this Section 18 shall survive the Closing.

 

19.            FORCE
MAJEURE EVENT.

 

Neither party
to this Agreement is liable nor in default for any delay or failure in performance under this Agreement, and such delay or failure of
performance shall not constitute a breach of this Agreement, if and to the extent that such delay or failure is the result of a Force
Majeure Event (as defined below). If a party intends to invoke this provision, that party shall provide notice to the other party as soon
as practicable. Each party shall exercise commercially reasonable efforts to mitigate the extent of such delay or failure. “Force
Majeure Event” shall mean catastrophic acts of terrorism, fire, explosion, earthquake, storm, flood, war, insurrection, tornado,
hurricane, other natural disasters, pandemics, quarantine restrictions or travel restrictions, sabotage, embargo, expropriation, riot,
acts of God or any comparable event or other state, national or international emergency, calamity or crisis, beyond the reasonable control
of the party seeking to excuse or delay performance under this Agreement.

 

(SIGNATURES ON FOLLOWING PAGE)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	13	 

     

    

 

IN WITNESS WHEREOF, the parties hereto
have duly executed this Agreement as of the day and year first above written.

 

 

	BUYER:	 	SELLER:
	 	 	 
	GOLDEN DEVELOPING SOLUTIONS INC/	 	 
	Subsidiary TBD	 	Jai Chamunda New Hudson LLC
	 	 	 
	/s/ Stavros Triant	 	By:
/s/ Shreya Mehta
	Stavros Triant	 	Name: Shreya Mehta
	CEO	 	Title: Member
	9/30/2022 | 8:07 AM PDT	 	9/30/2022 | 8:21 AM PDT

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	14	 

     

    

 

Exhibit 1

 

 

 

	Seller:	Jai Chamunda New Hudson LLC	Buyer: Golden Developing Solutions Inc
	 	 
	Store Location: 56270 Grand River Ave,	PO Box 460573
	 	New Hudson MI, 48165	Fort Lauderdale, FL 33346

 

 

 

 

PURCHASE PRICE & ALLOCATION:

 

	ASSET	PURCHASE PRICE
	Date of Inventory (Max. inventory amt)	$450,000.00
	Rx Data	$890,000.00
	Member’s Non-Compete	$10,000.00

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	15	 

     

    

 

BILL OF SALE

 

KNOW ALL PERSONS by these
presents that Jai Chamunda New Hudson LLC (“Seller") in consideration of the sum of __________ ($ __________.00) paid by Golden
Developing Solutions Inc, with a business address of __________ ("Buyer"), the receipt and adequacy of which is hereby acknowledged,
does hereby grant, sell, assign, transfer and deliver to Buyer, its successors and assigns, all of Seller's right, title and interest
in and to the Assets, including, without limitation, the Inventory and Seller’s Rx Data, as defined and described in the Purchase
and Sale Agreement dated __________, 2022, by and between Seller and Buyer, to have and to hold same unto Buyer, its successors and assigns,
forever.

 

Seller hereby
warrants, covenants and agrees that it is the sole lawful owner of said Assets, and that Seller will warrant and defend the sale of said
Assets hereby sold to Buyer, its successors and assigns, against all and every person and persons whomsoever.

 

Buyer and
Seller agree that a facsimile or .pdf signature on this Bill of Sale and the Closing Statement is as valid as an original signature.

 

IN WITNESS WHEREOF, Seller
has executed these presents this _____ day of ____________ , 2022.

 

 

	BUYER:	SELLER:
	 	 
	 	 
	_______________________________	By: _____________________________
	 	Name: 
	 	Title: ____________________________

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	16	 

     

    

 

Closing Statement

Purchase
and Sale Agreement

Dated __________, 2022

by and between

 

Jai Chamunda New Hudson LLC

And

Golden Developing Solutions Inc

 

 

The following is a listing of all payments to be made pursuant
to the above-referenced Asset Purchase and Sale Agreement.

 

	RX Inventory	$
	 	 
	Prescription Files	$
	 	 
	Covenant Not To Compete	$
	 	 
	 	 
	 	 
	Total	$

 

This
Closing Statement is acknowledged and agreed to this _____ day of __________, 2022.

 

 

BUYER:

 

By: ______________________

Name:
______________________

Title: ______________________

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	17	 

     

    

 

TO ENSURE PROMPT PAYMENT PLEASE
CONTACT YOUR RECEIVING BANK AND ASK THEM TO PROVIDE “SAME DAY WIRE TRANSFER” INSTRUCTIONS FOR ALL OF YOUR ACCOUNTS ON THEIR
LETTERHEAD WITH NO HANDWRITTEN NOTATIONS OTHER THAN A BANK OFFICER’S SIGNATURE.

 

 

 

 

 

WIRE TRANSFER INSTRUCTIONS ON BANK LETTERHEAD ARE THE
ONLY ACCEPTABLE FORM.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	18	 

     

    

 

SCHEDULE A

 

INVENTORY INSTRUCTIONS

 

Inventory Date:

 

Here is a list of Inventory Categories with Seller’s
cost.

 

	Category List	Seller’s Cost
	Brand Rx	$
	Generic Rx	$
	Controls	 
	Schedule II	$
	Schedule III	$
	Schedule III	$
	Schedule IV	$
	Schedule V	$

 

Partially filled (opened) stock containers of pharmacy
brand name and/ or generic drug product(s) will be counted by visually estimating to the nearest tenth (1/10) of the full container and
then multiplying the quantity in the container by the Seller’s cost.

 

EXCLUSION LIST

 

Any Non-Prescription Products containing Vaccines

 

Pharmacy Inventory Not In Its Original Container or Package

 

Pharmacy Inventory Which Will Outdate Within Sixty (60)
Days of the Inventory Date Sample Pharmacy Inventory

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	19	 

     

    

 

SCHEDULE 3(c)

 

LIST OF SECURED CREDITORS

 

Amerisource Bergen

McKesson
Corporation

Cardinal Health, D/B/A Parmed

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	20	 

     

    

 

DISBURSEMENT
AGREEMENT

 

This Disbursement Agreement dated
September 28, 2022 (the “Agreement”), is entered into by and among Jai Chamunda New Hudson, LLC, a Michigan
limited liability company (“Seller”), Golden Developing Solutions Inc, a Nevada Corporation (“Buyer”)
and SRX, LLC, a Tennessee limited liability company (“Stillwell”).

 

WHEREAS, Seller and Buyer entered
into an Asset Purchase and Sale Agreement dated September 28, 2022 (the “Purchase Agreement”), pursuant to which
Buyer agreed to deposit in escrow with Stillwell the sum of $25,000 (the “Deposit”).

 

WHEREAS, Stillwell has been requested
by Seller and Buyer to hold the Deposit in accordance with the terms of this Agreement and Stillwell has agreed to do the same solely
as an accommodation to Buyer and Seller in order to facilitate the disbursement of the Deposit.

 

NOW THEREFORE, in consideration
of the foregoing and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties
agree as follows:

 

1.             
Receipt of Deposit. Seller and Buyer acknowledge that the Deposit shall be received by Stillwell into Stillwell’s
separate bank account.

 

 2.              No Investment of Deposit. The Deposit shall not be invested by Stillwell.

 

3.             
Disbursements. Stillwell shall disburse the Deposit to accordance with the terms of the Purchase Agreement.

 

 4.              IRS Reporting.

 

(a)          
Seller and Buyer agree that, unless required by applicable law, Stillwell shall have no obligation to provide an Internal Revenue
Service form 1099 or any other documentation to any party with respect to any portion of the Deposit received by such party.

 

(b)           
If required under applicable law, Seller and Buyer shall provide any information reasonably requested by Stillwell prior to disbursement
of any portion of the Deposit to such party. Seller and Buyer understand that if such information is not provided to Stillwell, Stillwell
may be required by the Internal Revenue Code of 1986, as amended, and the regulations promulgated thereunder, to withhold a portion of
any interest or other income earned on the investment of the Deposit.

 

(c)           
To the extent that Stillwell becomes liable for the payment of any taxes in respect of income derived from the investment of the
Deposit, Stillwell shall satisfy such liability to the extent possible from the Deposit. Seller and Buyer, jointly and severally, shall
indemnify, defend and hold Stillwell harmless from and against any tax that may be assessed against Stillwell on or with respect to the
Deposit and the investment thereof unless such tax was directly caused by the gross negligence or willful misconduct of Stillwell. The
indemnification provided by this Section is in addition to the indemnification provided elsewhere in this Agreement and shall survive
the resignation of Stillwell and the termination of this Agreement.

 

5.             
Termination. Upon the disbursement of all of the Deposit, this Agreement shall terminate and be of no further force and
effect except that the provisions of Sections 4, 6, 7, 8, 9, 10, 12, 13 and 14 hereof shall survive termination.

 

 

 

    	 	21	 

     

    

 

6.             
Scope of Responsibility. Notwithstanding any provision to the contrary, (a) Stillwell is obligated only to perform the duties
specifically set forth in this Agreement, which shall be deemed purely ministerial in nature, (b) under no circumstances will Stillwell
be deemed to be a fiduciary to Buyer, Seller or any other person under this Agreement, (c) Stillwell will not be responsible or liable
for the failure of any party to perform in accordance with this Agreement, (d) Stillwell shall neither be responsible for, nor chargeable
with, knowledge of the terms and conditions of any other agreement, instrument, or document other than this Agreement, whether or not
an original or a copy of such agreement has been provided to Stillwell, (e) Stillwell shall have no duty to know or inquire as to the
performance or nonperformance of any provision of any such agreement, instrument, or document, (f) references in this Agreement to any
other agreement, instrument, or document are for the convenience of the parties, and Stillwell has no duties or obligations with respect
thereto, and (g) this Agreement sets forth all matters pertinent to the escrow contemplated hereunder, and no additional obligations of
Stillwell shall be inferred or implied from the terms of this Agreement or any other agreement.

 

7.             
Reliance. Stillwell shall not be liable for any action taken or not taken by it in accordance with the direction or consent
of the Parties or their respective attorneys, agents, representatives, successors, or assigns. Stillwell shall not be liable for acting
or refraining from acting upon any notice, request, consent, direction, requisition, certificate, order, affidavit, letter, or other paper
or document believed by it to be genuine and correct and to have been signed or sent by the proper person or persons, without further
inquiry into the person’s or persons’ authority.

 

8.             
No Financial Obligation. No provision of this Agreement shall require Stillwell to risk or advance its own funds or otherwise
incur any financial liability or potential financial liability in the performance of its duties or the exercise of its rights under this
Agreement.

 

9.            
Indemnification. Seller and Buyer, jointly and severally, shall indemnify, defend and hold harmless Stillwell from and against
any and all loss, liability, cost, damage and expense, including, without limitation, attorneys’ fees and expenses or other professional
fees and expenses which Stillwell may suffer or incur by reason of any action, claim or proceeding brought against Stillwell, arising
out of or relating in any way to this Agreement, except to the extent such loss, liability, cost, damage or expense shall have been finally
adjudicated to have been directly caused by the willful misconduct or gross negligence of Stillwell. The provisions of this Section shall
survive the resignation of Stillwell and the termination of this Agreement.

 

10.          
Limitation of Liability. STILLWELL SHALL NOT BE LIABLE, DIRECTLY OR INDIRECTLY, FOR ANY (A) DAMAGES, LOSSES OR EXPENSES
ARISING OUT OF THE SERVICES PROVIDED HEREUNDER, OTHER THAN DAMAGES, LOSSES OR EXPENSES WHICH HAVE BEEN FINALLY ADJUDICATED TO HAVE DIRECTLY
RESULTED FROM STILLWELL’S GROSS NEGLIGENCE OR WILLFUL MISCONDUCT, OR (B) SPECIAL, INDIRECT OR CONSEQUENTIAL DAMAGES OR LOSSES OF
ANY KIND WHATSOEVER (INCLUDING WITHOUT LIMITATION LOST PROFITS), EVEN IF STILLWELL HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH LOSSES
OR DAMAGES AND REGARDLESS OF THE FORM OF ACTION.

 

11.           
Resignation. Stillwell may resign by furnishing written notice of its resignation to Seller and Buyer. Such resignation
shall be effective immediately after the delivery of such notice, and Stillwell’s sole responsibility thereafter shall be to safely
keep the Deposit and to deliver the same to its successor under this Agreement as shall be appointed by Seller and Buyer, as evidenced
by a joint written notice delivered to Stillwell or in accordance with a court order. If the Parties have failed to appoint a successor
within thirty (30) days following the delivery of such notice of resignation, Stillwell may petition any court of competent jurisdiction
for the appointment of a successor or for other appropriate relief, and any such resulting appointment shall be binding upon the Parties.

 

 

 

    	 	22	 

     

    

 

12.          
Stillwell Legal Fees and Costs. In the event that (a) Stillwell is made a party to any litigation pertaining to this Agreement
or the subject matter hereof, or (b) Stillwell commences legal action or otherwise incurs internal or outside legal fees under this Agreement
(except in connection with the negotiation and drafting of this Agreement), then Stillwell shall be reimbursed for all costs and expenses
occasioned thereby, including reasonable attorneys’ fees and expenses incurred by Stillwell except to the extent that any such litigation
or event is finally adjudicated to have been directly caused by Stillwell’s gross negligence or willful misconduct. Seller and Buyer
shall be jointly and severally liable for all such amounts. If any amount due to Stillwell hereunder is not paid within thirty (30) days
of the date due, Stillwell in its sole discretion may charge interest on such amount at the lesser of (a) 8% per annum, or (b) the highest
rate permitted by applicable law. Stillwell shall have, and is hereby granted, a prior lien on the Deposit with respect to its unpaid
fees, non-reimbursed expenses and unsatisfied indemnification rights, superior to the interests of any of the Parties and is hereby granted
the right to set off and deduct any unpaid fees, non- reimbursed expenses and unsatisfied indemnification rights from the Deposit.

 

13.           
Disagreements. If any conflict, disagreement or dispute arises between, among, or involving Seller and Buyer concerning
the meaning or validity of any provision hereunder or concerning any other matter relating to this Agreement and/or the Purchase Agreement,
or Stillwell is in doubt as to the action to be taken hereunder, Stillwell may, at its option, retain the Deposit until Stillwell (a)
receives a final non-appealable order of a court of competent jurisdiction directing delivery of the Deposit, (b) receives a written agreement
executed by each of the parties involved in such disagreement or dispute directing delivery of the Deposit, in which event Stillwell shall
be authorized to disburse the Deposit in accordance with such final court order or agreement, or (c) files an interpleader action in any
court of competent jurisdiction, and upon the filing thereof, Stillwell shall be relieved of all liability as to the Deposit. Stillwell
shall be entitled to act on any such agreement or court order without further question, inquiry, or consent.

 

14.           
Attachment of Deposit; Compliance with Legal Orders. In the event that any Deposit shall be attached, garnished or levied
upon by any court order or lawful process, or the delivery thereof shall be stayed or enjoined by an order of a court, or any order,
judgment or decree shall be made or entered by any court order affecting the Deposit, Stillwell is hereby expressly authorized, in its
sole discretion, to respond as it deems appropriate or to comply with all writs, orders or decrees so entered or issued, or which it
is advised by legal counsel of its own choosing is binding upon it, whether with or without jurisdiction and provided notice thereof
to the parties. In the event that Stillwell obeys or complies with any such writ, order or decree it shall not be liable to any of the
parties or to any other person, firm or corporation, should, by reason of such compliance notwithstanding, such writ, order or decree
be subsequently reversed, modified, annulled, set aside or vacated.

 

15.           
Force Majeure. Stillwell shall not be responsible or liable for any failure or delay in the performance of its obligation
under this Agreement arising out of or caused, directly or indirectly, by circumstances beyond its reasonable control, including, without
limitation, acts of God; earthquakes; fire; flood; wars; acts of terrorism; civil or military disturbances; sabotage; epidemic; pandemics;
riots; interruptions, loss or malfunctions of utilities, computer (hardware or software) or communications services; accidents; labor
disputes; acts of civil or military authority or governmental action; it being understood that Stillwell shall use commercially reasonable
efforts to resume performance as soon as reasonably practicable under the circumstances.

 

16.          
Successors and Assigns. This Agreement shall be binding on and inure to the benefit of the parties and Stillwell and their
respective successors and permitted assigns. No other persons shall have any rights under this Agreement. No assignment of the interest
of any of the Parties shall be binding unless and until written notice of such assignment shall be delivered to the other Party and Stillwell
and shall require the prior written consent of the other Party and Stillwell (such consent not to be unreasonably withheld).

 

17.           
Escheat. The Parties are aware that under applicable state law, property which is presumed abandoned may under certain circumstances
escheat to the applicable state. Stillwell shall have no liability to the Parties, their respective heirs, legal representatives, successors
and assigns, or any other party, should any or all of the Deposit escheat by operation of law.

 

 

 

    	 	23	 

     

    

 

18.           
Notices. All notices, requests, demands, and other communications required under this Agreement shall be in writing, in
English, and shall be deemed to have been duly given if delivered (a) personally, (b) by facsimile transmission with written confirmation
of receipt, (c) by overnight delivery with a reputable national overnight delivery service, or (d) by email or by certified mail, return
receipt requested, and postage prepaid. If any notice is mailed, it shall be deemed given five days after the date such notice is deposited
in the United States mail. If notice is given to a party, it shall be given at the address for such party set forth below. It shall be
the responsibility of the Parties to notify Stillwell and the other Party in writing of any name or address changes. In the case of communications
delivered to Stillwell, such communications shall be deemed to have been given on the date received by Stillwell.

 

	 	If to Seller:	Jai Chamunda New Hudson, LLC
	 	 	56270 Grand River Ave, New Hudson MI, 48165
	 	 	 
	 	If to Buyer:	Golden Developing Solutions Inc
	 	 	P.O Box 460573, Fort Lauderdale, FL 33346
	 	 	 
	 	If to Stillwell: SRX, LLC	3426 Benham Avenue Nashville, TN 37215
	 	 	Email: guy@stillwellrx.com

 

19.           
Governing Law and Venue. The validity, construction and performance of this Agreement shall be governed by the laws of the
State of Texas and any legal proceeding arising out of or in connection with this Agreement initiated by any of the Parties or Stillwell
shall be brought in the state or federal courts located in the State of Texas, and the Parties and Stillwell consent to the exclusive
jurisdiction of said courts.

 

20.           
Entire Agreement. This Agreement constitutes the final and complete expression of all of the terms of the understanding
and agreement between the Parties and Stillwell with respect to the subject matter hereof, and this Agreement supersedes any and all prior
or contemporaneous negotiations, communications, understandings, obligations, commitments, discussions, agreements or contracts, whether
written or oral, between the parties and Stillwell with respect to the subject matter hereof.

 

21.           
Amendment. This Agreement may be amended, modified, superseded, rescinded, or canceled only by a written instrument executed
by the parties and Stillwell.

 

22.           
Waivers. The failure of any Party at any time or times to require performance of any provision under this Agreement shall
in no manner affect the right at a later time to enforce the same performance. A waiver by any Party to this Agreement of any such condition
or breach of any term contained in this Agreement, in any one or more instances, shall neither be construed as a further or continuing
waiver of any such condition or breach nor a waiver of any other condition or breach of any other term in this Agreement.

 

23.           
Headings. Section headings of this Agreement have been inserted for convenience of reference only and shall in no way restrict
or otherwise modify any of the terms or provisions of this Agreement.

 

24.           
Counterparts. This Agreement may be executed in counterparts, each of which shall constitute an original, but all of which,
when taken together, will constitute one in the same instrument. This Agreement may be executed by facsimile signature or any electronic
signature complying with the U.S. federal ESIGN Act of 2000 (e.g., www.docusign.com), such signature is deemed an original signature.
Copies of the execution copy of this Agreement or any amendment with one or more signatures sent by facsimile transmission or as a “PDF”
(portable document file) attached to an electronic mail message or other transmission method and any counterpart so delivered is deemed
to have been duly and validly delivered and is valid, fully enforceable, and effective for all purposes without a manually executed original.

 

25.           
Indemnification Obligations. All indemnification obligations of the Parties under this Agreement shall be joint and several.

 

 

 

 

 

    	 	24	 

     

    

 

IN WITNESS WHEREOF, this Disbursement Agreement has been
duly executed as of the date first written above.

 

 

	Jai Chamunda New Hudson LLC	 	Golden Developing Solutions Inc	 
	 	 	 	 
	 	 	 	 
	By:
/s/ Shreya Mehta	 	/s/ Stavros Triant	 
	Its: Member	 	Its: CEO	 
	9/30/2022 | 8:21 AM PDT	 	9/30/2022 | 8:07 AM PDT	 
	 	 	 	 
	SRX,
LLC	 	 	 
	 	 	 	 
	By: /s/ Guy Stillwell	 	 	 
	Its: Managing Member	 	 	 
	9/30/2022 | 8:22 AM PDT	 	 	 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	25Exhibit 10.2

 

PURCHASE AGREEMENT

 

THIS AGREEMENT,
made and entered into on September 2022, by and between of COD Management, LLC d/b/a Orchard Trails Pharmacy located at 23133 Orchard
Lake Rd. Suite 101, Farmington, MI 48336 ("Seller"), and Renown Pharmaceuticals, LLC a Delaware company with a notice address
of P.O. Box 460573, Fort Lauderdale, FL 33346. ("Buyer”).

 

W I T N E S S E T
H:

 

WHEREAS,
Seller desires to sell and Buyer desires to purchase certain merchandise, inventory, files, fixtures and equipment; and

 

NOW, THEREFORE,
in consideration of the promises and subject to the conditions in this Agreement, Buyer and Seller agree as follows:

 

1.             
Purchase of Assets. Seller will sell and Buyer will purchase the following assets currently utilized in the operation
of the Pharmacy ("Assets"):

 

a.            
Seller's salable and usable merchandise (90 Days Dating) inventory at the Pharmacy, as selected by Buyer, in Buyer's discretion,
on or before the Closing Date (the "Inventory"). The inventory purchased will be all legend pharmaceuticals, all non-legend
pharmaceuticals, all health care supplies and equipment, and all sundry, card, and gift items. The Inventory will be valued at the original,
actual cost to Seller. Cost for any particular item of Inventory will be demonstrated by Seller to Buyer in a manner reasonably satisfactory
to Buyer, when so requested.

 

b.             
Non-leased furniture, fixtures, equipment, computers, transferable software, telephone numbers, and other items of a similar
nature including fixtures and equipment at the Pharmacy as of [enter date], [enter year] and listed on Exhibit A attached to this Agreement.
The value of the Fixtures and Equipment is ten thousand dollars ($10,000).

 

c.             
All prescription lists, patient profiles, customer lists, prescription files, and other records relating to the Pharmacy (the
"Files"), and goodwill as of the Closing Date, including such information maintained in computer memory, on disks or by other
electronic means. The value of the Files and goodwill is two hundred and fifty-five thousand dollars ($255,000).

 

d.            
A covenant not to compete which will be binding upon Seller, and its officers, directors and shareholders (if any) (the "Non-Compete").
The value of the Non-Compete is ten thousand dollars ($10,000).

 

2.            
Purchase Price. The purchase price for the Assets (the "Purchase Price") will be the sum of the Cost of the
Inventory, and the agreed values of the Fixtures and Equipment, Files, Non-Compete. Buyer and Seller shall cooperate in the preparation
of Internal Revenue Service Form 8594, entitled Asset Acquisition Statement under Section 1060, or any other similar form required to
be filed by Buyers or Sellers under the Internal Revenue Code of 1986, as amended.

 

 

 

    	 	1	 

     

    

 

3.              Payment
of Purchase Price. Buyer will pay the Purchase Price in the following manner:

 

		a.	Purchase Price will be paid in full at the Closing.

 

If any
creditor of Seller has a security interest, lien or other right in, or with respect to any of the Assets (a "Lien"), other
than a mortgage or deed of trust on the premises occupied by the Pharmacy, Buyer will have the right (but not the obligation) to either:
(a) deduct from the Purchase Price the amount necessary to release the Lien and pay such amount directly to the appropriate party for
a release; or (b) terminate this Agreement if the amount necessary to release such Lien exceeds ten percent (10%) of the Purchase Price.

 

4.             
Inventory Audit. The total Cost of the Inventory will be determined by a third party (the "Inventory Service")
on the evening prior to the Closing Date, according to the terms set out in paragraph a of Section 1 of this Agreement. The Inventory
Service will be approved by Seller and Buyer, and the cost of this service will be divided equally between Seller and Buyer. Buyer will
be permitted to perform its own physical audit of the Inventory before the Closing.

 

5.            
Unsold Merchandise. All merchandise, inventory, fixtures, equipment and other items of property located at the Pharmacy
which are not being sold to Buyer will remain the property of the Seller.

 

6.            
NonAssumption of Liabilities. Buyer is neither purchasing nor assuming any of the debts, obligations or liabilities
of Seller (including, but not limited to, any debts, obligations or liabilities relating to the pharmacy business).

 

7.            
Closing Date. The purchase and sale of the Assets will be closed on or before October 14, 2022, (the "Closing Date")
at the Pharmacy or at such other time and place as the parties may agree in writing. Except as otherwise provided in this Agreement, at
the closing all instruments, documents and papers required to close the purchase will be executed by Buyer and Seller, the balance of
the Purchase Price will be paid to Seller and possession of the Assets will be delivered to the Buyer.

 

8.            
Representations and Warranties of Seller. Seller makes the following representations and warranties, which have been
relied upon by Buyer in entering into this Agreement:

 

a.             
No Violation of Law or Breach of Agreement. The execution of this Agreement, the sale of the Assets and the performance
of Seller's obligations in this Agreement will not violate any federal, state or local law, or conflict with, or result in a breach of,
any of the terms, provisions or conditions of, or constitute a default under, any agreement or other instrument to which Seller is a party
or by which Seller or any of the Assets may be affected.

 

b.             
Ownership and Right to Convey. Seller owns, and has good and marketable title to the Assets, and can sell, assign and
transfer the Assets free and clear of any liens, encumbrances, charges or claims of third parties. Furthermore, when the purchase of the
Assets is closed, Buyer will own the Assets free and clear of any such liens, encumbrances, charges or claims of third parties. All legal
actions necessary to effect the sale by Seller to Buyer of the Assets pursuant to this Agreement have been (or will be prior to the Closing
Date) taken by Seller. Except as a result of sales in the ordinary course of business prior to the Closing Date, Seller will not remove
any Assets from the Pharmacy without the written consent of Buyer.

 

c.            
Occupation of Pharmacy. Seller's business at the Pharmacy does not violate any zoning, building, fire or other statutes,
ordinances, rules, regulations, leases or encumbrances relating to the Pharmacy or the Assets, and no notices of any violation or claimed
violation of such statutes, ordinances, rules, regulations, leases or encumbrances have been received by Seller.

 

 

 

    	 	2	 

     

    

 

d.            
Litigation. No judgments, liens, actions, arbitrations, decrees, investigations or proceedings are pending or threatened
before any court or before any federal, state, municipal or other governmental body, commission or agency against Seller which have not
been fully disclosed in writing to Buyer and attached as an exhibit to this Agreement.

 

e.              Labor.

 

i.             
Seller has not entered into any contracts or commitments with its present or former employees at the Pharmacy that are not
cancelable by Seller on notice of not more than thirty (30) days without liability, penalty or premium;

 

ii.            
Seller has no collective bargaining or employment agreements, nor any agreements that contain any severance or termination
pay liabilities or obligations with employees at the Pharmacy;

 

iii.           
Seller has no bonus, deferred compensation, profit sharing or retirement benefit or allowance due or to come due to any employee
or former employee at the Pharmacy;

 

iv.           
All liability for bonuses, deferred compensation or retirement benefits, if any, accrued prior to the respective time of closing,
will remain the liability of the Seller; and,

 

v.             
Seller knows of no group, organization or union which has tried to organize any employee(s) of Seller within the last three
(3) years.

 

f.             
Conditions of Assets. The Fixtures and Equipment to be sold under this Agreement are and will on the Closing Date be,
in the same quantity, condition and repair as on the date of this Agreement.

 

g.            
Taxes. Seller has timely, filed with the appropriate governmental agencies, all tax returns and tax reports due and
required to be filed by Seller, including all federal, state and city profits, income, sales, use, occupation, property, excise, social
security, withholding, unemployment insurance, licenses and other taxes and has paid or has provided for the payment of all such taxes
through the Closing Date. Seller has no notice or knowledge of any pending examinations pertaining to or claims for, taxes or assessments
asserted against Seller by any taking authority in respect of any period prior to the Closing Date. Seller agrees to pay all sales and
transfer taxes of any nature whatsoever due or becoming due as a result of the sale of the Assets under this Agreement.

 

h.            
Insurance. Seller has complied, and between now and the Closing Date will continue to comply, with all fire, casualty
and other safety standards common to the business carried on by Seller at the Pharmacy or imposed by any federal, state or local authority.
Seller has maintained, and will continue to maintain through the Closing Date, property and casualty insurance on the Assets and the Pharmacy
business, including extended coverage endorsements, in an amount equal to the full replacement value of the Assets and the Pharmacy business,
without co-insurance other than a typical deductible for the type of Pharmacy business operated by the Seller.

 

i.             
Disclosure. No representations or warranties in this Agreement, nor any information, schedule or exhibit furnished,
or to be furnished to Buyer, nor any document delivered to Buyer will contain any untrue statement of a material fact or will omit a material
fact necessary to make the statements contained therein not misleading.

 

j.             
Good Standing. If the Seller is a corporation, it is existing and in good standing under the laws of the State of Michigan.

 

 

 

 

    	 	3	 

     

    

 

k.             Regulatory
and Third Party Payers.

 

		i.	With the exception of BCBS of Michigan, all PBMs available from the pharmacy’s
PSAO are under contract with the pharmacy, as well as Michigan Medicaid and Change Healthcare.
		ii.	There are no pending audits.
		iii.	There are no, and have not been, any adverse letters
or investigations from any PBM, Medicare, Medicaid or OIG.
		iv.	There has not been any adverse communication from any
payer regarding billing, ordering, dispensing, or company policy and procedures.
		v.	There has been no negative inspection reports with the
Michigan Board of Pharmacy.
		vi.	There has not been, or currently undergoing, a DEA inspection, and there has been no inquires from DEA regarding the operation of
the pharmacy.

 

9.            
Representations and Warranties of Buyer. The Buyer represents and warrants, to its best knowledge, that the execution
of this Agreement, the purchase of the Assets and the performance of Buyer's obligations in this Agreement will not violate any federal,
state or local law, or conflict with, or result in a breach of, any of the terms, provisions or conditions of, or constitute a default
under, any agreement or other instrument to which Buyer is a party or by which Buyer or any of the Assets may be affected.

 

10.          
Actions Pending Closing. From the date of this Agreement until and through the Closing Date, and any extensions or postponements
of the Closing Date:

 

a.             
Full Access. Seller will permit Buyer's employees and other authorized representatives access to the Pharmacy, so Buyer
may have the opportunity to investigate and inspect. Seller will make available to Buyer copies of all financial statements, books, records,
tax returns or other documents or instruments affecting the operation of the Pharmacy.

 

b.            
Carry On Business In Regular Course. Seller will continue to operate the pharmacy in its normal and customary manner
to preserve the business of the pharmacy and will not close the pharmacy on any day or at any time when the pharmacy is not normally closed
or make any changes in the policies or methods of operations without buyer's prior written consent. Seller will keep and maintain all
of the assets of the pharmacy in good order and repair, ordinary wear and tear through reasonable and careful use excepted. There will
be no transfers of any assets in or out of the pharmacy after the date of this agreement outside the course of regular business, without
buyer's prior written consent.

 

11.          
Covenant Not to Compete. Seller, and the officers, directors and shareholders, or those associated with Seller in the
Pharmacy business, if any (collectively the "Owners"), will not directly or indirectly engage in or become interested in a pharmacy
business or any business or activity incidental to the pharmacy business (including the providing of pharmacy services to skilled and
nonskilled nursing facilities) or become the agent or employee of any competitor of Buyer, or in any other way compete with Buyer, (or
Buyer's assignee, should the assets transferred hereunder to resold by Buyer), within an area encompassing a radius of ten (10) miles
from the location of the Pharmacy for a period of three (3) years from the Closing Date. In addition, Owners will not, directly or indirectly,
attempt to divert, take away, or solicit any customers of the Pharmacy, including those with which Owners had contact prior to the Closing
Date, for a period of three (3) years from the Closing Date; and, Owners represent and warrant that they have not done so at any time
since January 1, 2022. Owners acknowledge that any remedy at law for breach of this covenant would be inadequate and that Buyer will be
entitled to injunctive relief to enforce this Section 12, in addition to any other legal remedies available to Buyer for such breach of
this Section 12. Owners acknowledge that the area covered by the covenant not to compete, and the nature and duration of the restrictions
in this Section 12, are reasonable and necessary for the proper protection of Buyer. If any part of this Section 12 is invalidated, the
remainder of this Section 12 will nevertheless continue to be valid and enforceable. If anyone successfully contests the validity or enforceability
of this Section 12 in its present form predicated upon the duration or area of coverage, this provision will not be deemed invalid or
unenforceable, but will instead be deemed modified, so as to be valid and enforceable, to provide coverage for the maximum duration that
any Court of competent jurisdiction will deem reasonable, necessary and equitable.

 

 

 

    	 	4	 

     

    

 

12.          
Delivery of Prescription Lists and Other Items. Seller will deliver to Buyer, on or prior to the Closing Date, all prescription
lists, patient profiles, customer lists, prescription files, and other records relating to the Pharmacy, including those maintained by
computer memory or other electronic means, and will not retain any copies. All such information contained in computer memory or data recording
systems connected with computers will be retained in such form so that Buyer will have full access.

 

13.          
Conditions Precedent to Buyer's Obligation to Close. The obligation of the Buyer to close the purchase of the Assets
is subject to the following conditions which, unless waived by Buyer, must be satisfied on or prior to the Closing Date:

 

a.             
Representations and Warranties. The representations and warranties made by Seller in this Agreement will be true, complete
and accurate in all material respects on and as of the Closing Date with the same effect as though such representations, warranties and
covenants had been made or given on and as of the Closing. Seller will deliver a certificate to Buyer at closing re- affirming the warranties
and representations.

 

b.             
No Material Change. The business, assets and properties of Seller at the Pharmacy will not have been materially adversely
affected as a result of fire, explosion, earthquake, disaster, accident, casualty, labor dispute or other disruption which cannot be resolved
without material adverse effect, change in the business organization, any action by the United States or of any other governmental authority;
or by flood, drought, embargo, riot, civil disturbance, uprising, activity of armed forces or act of God or public enemy. Seller will
deliver a certificate to Buyer to that effect. If Buyer waives its right to terminate the Agreement under this paragraph b, all insurance
proceeds payable to Seller as a result of such event will be assigned to and paid over to Buyer at closing or when the proceeds are received,
whichever is later, and Seller will cooperate with Buyer to obtain such proceeds.

 

c.             
Compliance with Agreement. Seller will have performed and complied in all material respects with all obligations under
this Agreement which are to be performed or complied with on or prior to the Closing Date.

 

d.             
Proceedings and Instruments Satisfactory. All documents required by Buyer under this Agreement will have been delivered
to Buyer.

 

e.             
Assignment. Buyer may assign this Agreement to any other person or entity without Seller's consent. Any assignment by
Buyer will relieve Buyer of any liability for the performance of Buyer's obligations under this Agreement. Seller's obligations and benefits
hereunder are not assignable without Buyer's prior written consent.

 

f.             
Property Lease Agreement.This purchase agreement is contingent upon the successful execution of a lease, or assignment
of current lease, upon approval of Buyer, which approval shall not be unreasonably withheld, at the current location of the Pharmacy.
The terms of the lease must be approved by the Buyer, in writing, on or before October 13, 2022.

 

g.             
Taxes.Seller will have paid all taxes due any governmental authority arising from this transaction.

 

 

 

    	 	5	 

     

    

 

14.          
Indemnity and Hold Harmless Agreement. The representations, warranties and agreements made by Seller in this Agreement
will survive the closing, regardless of any inquiry that may have been made by Buyer or Seller. Seller will indemnify and hold Buyer harmless
from any liability or expenses resulting from a breach of this Agreement by Seller or the inaccuracy or breach of any representation,
warranty or agreement contained in this Agreement or in any certificate, document, list, schedule, exhibit or instrument delivered to
Buyer by or on behalf of Seller under this Agreement, including reasonable attorney's fees incurred by Buyer to defend or prosecute any
action or proceeding resulting from any breach or inaccuracy. This agreement to indemnify and hold the Buyer harmless will include any
liabilities, claims, costs, demands or losses of any nature incurred by Buyer.

 

15.          
Risk of Loss. Seller retains all risk of loss due to fire or other casualty from the date of this Agreement through
the closing of the sale of the Assets. If a fire or other casualty occurs prior to the closing, Seller shall immediately notify Buyer
and provide a complete description of the damage caused to the Pharmacy. Buyer will send written notice to the Seller, within thirty
(30) days after the receipt of Seller's notice of the fire or other casualty, and may elect either: (i) to close the purchase, with the
Purchase Price reduced by the amount by which the value of the Inventory, and Fixtures and Equipment is reduced by the fire or other
casualty, as determined by an adjuster or appraiser selected by Buyer; or, (ii) if such loss exceeds $1,000.00 in value, to terminate
this Agreement and Buyer and Seller will have no further liability under this Agreement. If the Closing Date will occur in less than
thirty (30) days from the date of Seller's notice to Buyer, in addition to the other rights granted to Buyer in this Section 17, Buyer
may postpone the Closing Date by not more than thirty (30) days to permit adequate time to make its election.

 

16.
          General Provisions.

 

a.             
Entire Agreement. This Agreement is the entire agreement between Buyer and Seller, and no agreements, representations
or warranties have been made other than those in this Agreement, except as appear on the Exhibits attached to this Agreement. This Agreement
may not be modified except by a writing executed by Buyer and Seller.

 

b.             
Successors and Assigns. This Agreement is binding upon and inures to the benefit of, and may be enforced by Seller and
Buyer and their respective successors and assigns.

 

c.            
Joint and Several Obligations of Seller. If this Agreement is signed by more than one person on behalf of Seller, including
any director, officer or shareholder of Seller, the obligations of all persons or entities signing this Agreement on behalf of Seller
shall be joint and several. If this Agreement is breached by Seller, Buyer may proceed separately against the Seller and each of the persons
who have executed this Agreement on behalf of Seller. A release or covenant not to sue any of such persons or entities shall not relieve
any other person or entity of liability under this Agreement.

 

d.             Notices.
All notices, requests, demands and other communications hereunder will be deemed to have been duly given if delivered by hand, mail
(certified or registered with postage prepaid, return receipt requested) or overnight courier as follows:

 

		a.	If to the Buyer: Renown Pharmaceuticals, LLC
	 	 	P.O Box 460573,
	 	 	Fort Lauderdale, FL 33346
	 	 	 
		b.	If to the Seller:

 

e.            
Severability. If any one or more of the provisions in this Agreement or any application of the provisions of this Agreement
is declared invalid or illegal or unenforceable by any court of competent jurisdiction, the validity, legality or enforceability of the
remaining provisions of this Agreement will not be impaired by such declaration, and this Agreement will be construed as if such invalid,
illegal or unenforceable provision was not contained in this Agreement.

 

 

 

    	 	6	 

     

    

 

17.          
Seller's Assistance After Closing. Seller will assist Buyer in carrying out an orderly transition of the business of
the Pharmacy to Buyer from and after the Closing Date. Such assistance may include, but not be limited to, securing the employment of
such of Seller's employees as Buyer desires; making application to third party payment programs to transfer accounts to Buyer; and, transferring
utility, telephone and other service accounts to Buyer. Seller agrees to provide Buyer with Power of Attorney, as attached in Exhibit
B, for use of State pharmacy License, DEA registration, NCPDP and NPI numbers, Medicaid/Medicare provider accounts and third party contracts
in order to carry out an orderly transition of business and transition of patient care.

 

18.           Transfers
on Closing Date. On the Closing Date, Seller will deliver to Buyer:

 

a.            
A bill of sale and all other instruments or assignments necessary to transfer title to the Assets, free and clear of all liens,
security interests and encumbrances, containing, where required, joint and several warranties. The bill of sale will otherwise be in form
satisfactory to Buyer and Buyer's counsel.

 

b.             
All other agreements, instruments and documents as may be reasonably required by Buyer to close the purchase and sale of the
Assets referred to in this Agreement.

 

EXECUTED AND AGREED
TO ON THE DAY AND YEAR FIRST ABOVE WRITTEN.

 

	SELLER:	 	BUYER:
	 	 	 
	 	 	 
	By:
/s/ Zaher Beydoun	 	/s/ Stavros Triant
	Name/Title: Zaher Beydoun	 	Name/Title: Stavros Triant
	Date: 9/22/2022		Date: 9/23/2022

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	7	 

     

    

 

 

EXHIBIT A

 

To the Purchase
Agreement between:

 

COD Management, LLC d/b/a Orchard Trails Pharmacy ("Seller")
and and Renown Pharmaceuticals, LLC ("Buyer")

 

 

 

LIST OF FIXTURES, EQUIPMENT & SUPPLIES

 

CHECK IF

APPLICABLE

 

		3⁄4	EXTERIOR SIGN ON ALL SIDES OF BUILDING
		3⁄4	LIGHTED POLE SIGN OUT FRONT OF BUILDING
		3⁄4	LETTERS ON FRONT OF BUILDING
		3⁄4	DESKS, TABLES, RECOMM SIGN, ETC.
		3⁄4	ALL FILE CABINETS AND FURNITURE
		3⁄4	RECEPTION AREA CHAIRS (    )
		3⁄4	CHAIRS OTHER (    )
		3⁄4	VACUUM
CLEANER _________________________
		3⁄4	CASH REGISTER _________________________
		3⁄4	TYPEWRITERS AND ALL COMPUTER EQUIPMENT AND SUPPLIES
		3⁄4	DRUG BAYS
		3⁄4	ALL PHARMACY FIXTURES AND SUPPLIES
		3⁄4	REFRIGERATOR
		3⁄4	SINK AND CABINETS
		3⁄4	OTC BAYS
		3⁄4	PHARMACY BALANCE AND WEIGHTS AND RELATED SUPPLIES
		3⁄4	CARPET, DROP CEILING, LIGHT FIXTURES, FIREWALL AND DOOR PANELING, ETC.
		3⁄4	BOOKS AND EQUIPMENT REQUIRED BY BOARD OF PHARMACY
		3⁄4	PRESCRIPTION FILES AND RECORDS
		3⁄4	SIDEWALK, GARDEN ITEMS, AND MISCELLANEOUS TOOLS
		3⁄4	ALL OTHER FIXTURES, EQUIPMENT, AND SUPPLIES ON PREMISES
	 	 	______________________________________________________________________
	 	 	______________________________________________________________________
	 	 	______________________________________________________________________

 

 

 

    	 	8

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00349-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00349-of-00352.parquet"}]]